Cryo-Cell International Inc (CCEL) company profile
Close on Nov 13, 2026Market cap $39.10MP/E –Yield –
About Cryo-Cell International
Services-Misc Health & Allied Services, NEC, SIC 8090
Cryo-Cell International operates as a cellular processing and cryogenic storage company. It conducts business across three primary segments: cellular processing and cryogenic storage for family use, the manufacture of PrepaCyte CB processing system units, and cellular processing and cryogenic storage of cord blood stem cells for public use. The company collects, processes, and preserves stem cells derived from umbilical cord blood and cord tissue. Its principal clients are expectant parents seeking to preserve cellular materials for potential future medical treatments for their newborns or immediate family members.
The company is headquartered in Oldsmar, Florida, where it maintains an 18,000-square-foot facility handling administrative operations, marketing, client services, processing, and specimen storage. Cryo-Cell also owns a 56,000-square-foot facility located in Durham, North Carolina, which primarily houses its cryogenic storage units for specimen preservation. Together with its global affiliates, the organization stores more than 250,000 cord blood and cord tissue specimens worldwide.
Summary of the business section of Cryo-Cell International's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Cryo-Cell International Inc
- Founded
- 1989
- Headquarters
- Oldsmar, FL
- Address
- 700 Brooker Creek Blvd, Suite 1800 34677
- Phone
- (813) 749-2104
- Website
- cryo-cell.com
- Employees
- 72, Nov 30, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- November 30
- Auditor
- Wipfli LLP, Atlanta, Georgia
Stock & identifiers
- Ticker
- CCEL
- Exchange
- NYSE
- Shares outstanding
- 8M, Oct 8, 2026
- Public float
- $26.52M, May 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 862692
- CUSIP
- 228895108
- ISIN
- US2288951088
- FIGI
- BBG000BS6ZT0
- Share class FIGI
- BBG001S6Z7X3
- LEI
- 254900AQWFD6AR2J7Z30
- EIN
- 22-3023093
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| David Portnoy | Chairman, Co-CEO, Director | 1,620,164 |
| Mark L. Portnoy | Co-CEO, Director | 935,768 |
| Jill M. Taymans | VP Finance, CFO | 52,896 |
| Oleg Mikulinsky | Chief Information Officer | 104,349 |
| Harold D. Berger | Director | 64,031 |
| Daniel Mizrahi | Director | 30,634 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 David Portnoy | $1.62M | $701.94K | $373.13K | $108 | – |
| FY2025 Mark Portnoy | $1.09M | $762.82K | $373.13K | $108 | – |
| FY2024 David Portnoy | $1.63M | $2.27M | $378.74K | $204 | – |
| FY2024 Mark Portnoy | $1.08M | $1.32M | $378.74K | $204 | – |
| FY2023 David Portnoy | $1.64M | $1.84M | $353.50K | $122 | – |
| FY2023 Mark Portnoy | $1.09M | $1.16M | $353.50K | $122 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Option awards | Total | vs. prior year |
|---|---|---|---|---|---|
| David Portnoy Co-Chief Executive Officer | $741.12K | $750.00K | $127.40K | $1.62M | -0% |
| Mark Portnoy Co-Chief Executive Officer | $571.72K | $450.00K | $63.70K | $1.09M | +0% |
| Jill Taymans Vice President Finance, Chief Financial Officer | $280.00K | $20.00K | $26.69K | $326.69K | -2% |
| Oleg Mikulinsky Chief Information Officer | $329.89K | $63.00K | $26.69K | $419.58K | -1% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Employees
Headcount reported in annual reports
“At November 30, 2025, the Company had 72 full-time employees and 4 part-time employees on the staff of the Company.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?